India’s Leading Medical Devices Company Acquires UK-Based Penlon

BPL Medical Technologies acquisition of Penlon will complement existing portfolio and will help in expanding its presence in critical care segment.

India-based medical device company, BPL Medical Technologies (BPL Medical) acquired the UK-based Penlon Ltd (Penlon).

"We have acquired Penlon, a UK-based, leading global manufacturer of anesthesia systems and vaporizers with worldwide distribution networks. The acquisition will increase BPL Medical's presence and distribution in other emerging and developed markets," BPL Medical Technologies said in a statement.

First Indian Bill that Creates a Distinction Between Drugs and Medical Devices
Currently, 14,000 types of medical devices exist, out of which only 22 are present in the government's list and even those are treated as drugs.

Penlon's product range complements BPL Medical's existing portfolio and will help in expanding its presence in critical care segment. Penlon will continue to be based in and operated from the UK under the leadership of the existing management team, it added.

Penlon is an internationally recognised brand in critical care segment with a footprint in 96 countries, including India. With a strong focus on product innovation and a leading position in developed and emerging markets, the company designs, engineers and manufactures anesthesia systems, vaporizers and other complementary products.

These products are sourced by hospitals, pharmaceutical companies and anesthesia system manufacturers worldwide.

US-India Business Council: Indian Medical Device Industry can Grow to $7.7 Bn by 2016
The Indian medical device industry is going through rapid transformation, and it is expected to grow at a rate of 10 to 15 percent annually.

BPL Medical is one of the leading domestic medical device companies with over 300 personnel and a nationwide distributor network. In August 2013, Goldman Sachs invested in BPL Medical to fund the expansion of its medical devices business.

"This acquisition will help us penetrate the large critical care segment in India with Penlon's world-renowned, technology-driven anesthesia machines and vaporizers," said Sunil Khurana, Chief Executive Officer, BPL Medical.

First Medical Device Cleared By Regulatory Authorities To Measure Medication Adherence
Proteus ingestible sensors embedded in smart pills can transmit data to skin-worn receiver patches that communicates to a smartphones via Bluetooth.

BPL Medical will also leverage Penlon's R&D capabilities to develop many new products suitable for India and other emerging markets. Additionally, Penlon's global reach will help expand BPL Medical's international presence, Khurana added.

This partnership secures a long term investment which underpins our product strategy to develop world class anesthesia machines, monitors and next-generation vaporizers over the coming years.

Indigenous Medical Device Gets European Nod for Export
It was announced that an indigenously manufactured haematology analyser has become the first Indian product in its category to get a certification for export to European markets.

"We now plan to expand our product development capabilities across the business and will bring forward a number of key projects," said Stephen Moon, Chief Executive Officer, Penlon.

We will also benefit from BPL Medical's strength in India which will provide substantial growth in the years to come, said Moon.

Source-PTI